Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.995 USD | +1.98% | +8.64% | -19.02% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.02% | 1.87B | |
-2.11% | 103B | |
+0.82% | 95.71B | |
+1.69% | 22.02B | |
-17.15% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.93% | 15.52B | |
+3.43% | 13.86B | |
+34.27% | 12.04B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Signs Neuroscience, Oncology Collaboration Deal With Roche, Genentech -- Shares Rise